All News

REMORA app and wearables provided data that showed positive outcomes with better information about short-lived flares, better self-awareness of the disease and better conversations and more personalised care, Dixon W #ACR18

Dr. Antoni Chan synovialjoints ( View Tweet)

checkpoint inhibitor-related myositis associated with poor outcomes. #2976 @RheumNow @HealioRheum #ACR18

Cassandra Calabrese CCalabreseDO ( View Tweet)

Great summary in the ⁦@ACRheum⁩ Daily News of the ‘2018 Great Debate examines questions about hydroxychloroquine dosing guidelines’ #ACR18 https://t.co/ZKkrcixo5v

Links:

Paul Sufka, MD psufka ( View Tweet)

Would you leave ABIM and join alternate board certification bodies (eg: ABAI: American Board of Allergy and Immunology). ACR is looking into making a new combined board Am Board if Allergy, Immunology, and Rheumatology — ABAIR

k dao KDAO2011 ( View Tweet)

This comes up in real life, and will challenge your clinical skills. #ACR18 https://t.co/O03w6J9r9e

Links:

Paul Sufka, MD psufka ( View Tweet)

Digital pain reduction kit. VR device and TENS unit. #ACR18 https://t.co/pwD2B15HSv
Paul Sufka, MD psufka ( View Tweet)
Questions about checkpoint inhibitors: Are immune-related AEs predicative of cancer therapy response? Will immunosuppressives required to treat patients with immune related AEs blunt the anti-tumoural effects? Mixed results to date. @RheumNow #ACR18

Maeve Gamble MaeveGamble ( View Tweet)

Fun fact: Anti-Ro and -La were named after patients named Robair and Latiner 🤓 #lupus #ACR18 @RheumNow

Maeve Gamble MaeveGamble ( View Tweet)

This is why it's important that rheumatologists discuss contraception and family planning with their patients. https://t.co/9YPNGsZsGP

Links:

Maeve Gamble MaeveGamble ( View Tweet)

There is NO reason to withhold folate on day of MTX. Folic acid does not enter the cell via the RFC (folinic acid does). Therefore no evidence for competition. - Dr Joel Kremer @RheumNow #ACR18 🤔

Maeve Gamble MaeveGamble ( View Tweet)

Want to help reduce the wait time for people to get in to see a rheumatologist? Donate to the ACR Rheum Research Foundation! In addition to funding research to cure arthritis, @RheumResearch funds training programs like the one I trained at #Georgetown #ACR18 https://t.co/dfkrdLlaNE
Angus Worthing MD AngusWorthing ( View Tweet)
Breast feeding update in Rheumatic Patients: TNF inhibitors as a class are compatible with breast feeding. Prednisone doses < 20 mg/day OK for breast feeding. Patients on higher doses should delay breast feeding for four hours after administration #ACR18 #CleClinicRheum

Emily Littlejohn ELittlejohnDO ( View Tweet)

#ACR18 Short term relief during breastfeeding: 🌼 NSAIDs are compatible (ibuprofen preferred - short acting) 🌼 prednisone <20mg a day compatible 🌼 if using prednisone >20mg a day, then delay breastfeeding or discard milk for 4hr after administration

Kanika Monga, MD DrKanikaMonga ( View Tweet)

#ACR18 social media dinner with @rheumecraig @samwhittle @DrBhana @alhkim @jeffsparks @EBRheum @PhilipGardiner @BeckySueToo https://t.co/Kw0FejsnIE
Paul Sufka, MD psufka ( View Tweet)
Here's a view from the other direction from @DrBhana's phone. #ACR18 https://t.co/P6Ewkw3fxC
Paul Sufka, MD psufka ( View Tweet)
Thread: #ACR18 Round up with @RheumNow & Dr Kavanaugh. https://t.co/xqOs5LjwGi
Paul Sufka, MD psufka ( View Tweet)
Abstract 428. Pain reduction over 12 months using methotrexate for knee osteoarthritis. Good study: RCT, 12 months, statistically significant pain reduction in knee pain. (by comparison, MTX doesn't work for hand OA) #ACR18 https://t.co/lwdNNZvR0R
Paul Sufka, MD psufka ( View Tweet)
Abstract 221: DIP involvement in RA is about 2%. More women than men, and more in pts with higher disease activity. Might be poor prognostic indicator. #ACR18 https://t.co/YQR8kknRTl
Paul Sufka, MD psufka ( View Tweet)
Abstract 2220: gout flares and allopurinol use population study. Unfortunately, gout is *vastly* undertreated. Similar abstracts 1247, 1272 show that pharmacist driven gout care can work well #ACR18 https://t.co/09A85ehnf1
Paul Sufka, MD psufka ( View Tweet)
Abstract 404: using IL-17 inhibitor to treat supraspinatus tendinopathy in a rat model. This is a common shoulder tendinopathy, and IL-17 Involved in human cases. #ACR18 https://t.co/KwK6slNqA5
Paul Sufka, MD psufka ( View Tweet)
×